SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000812796-08-000041
Filing Date
2008-12-01
Accepted
2008-12-01 14:47:37
Documents
3
Period of Report
2008-11-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8K FOR SIGMA TAU LOI sigmatauloi8k.htm 8-K 29969
2 SIGMA TAU LOI sigmatauloi.htm EX-10.1 31785
3 PRESS RELEASE SIGMA TAU pressreleasesigmatauloi.htm EX-99.1 21873
  Complete submission text file 0000812796-08-000041.txt   85408
Mailing Address 850 BEAR TAVERN ROAD SUITE 201 EWING NJ 08628
Business Address 850 BEAR TAVERN ROAD SUITE 201 EWING NJ 08628 609-538-8200
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 081221924
SIC: 2834 Pharmaceutical Preparations